nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Addition of Cilostazol to Aspirin and a Thienopyridine for Prevention of Restenosis After Coronary Artery Stenting: A Meta-Analysis
|
Jennings, Douglas L. |
|
2010 |
50 |
4 |
p. 415-421 |
artikel |
2 |
Cardiovascular Effects of Ketamine in Sick Patients: Should Physicians Be Concerned?
|
Karnwal, Abhishek |
|
2010 |
50 |
4 |
p. 482-482 |
artikel |
3 |
Composite Functional Genetic and Comedication CYP2D6 Activity Score in Predicting Tamoxifen Drug Exposure Among Breast Cancer Patients
|
Borges, Silvana |
|
2010 |
50 |
4 |
p. 450-458 |
artikel |
4 |
Effects of Milnacipran on Cardiac Repolarization in Healthy Participants
|
Periclou, Antonia |
|
2010 |
50 |
4 |
p. 422-433 |
artikel |
5 |
Erratum
|
|
|
2010 |
50 |
4 |
p. 483-483 |
artikel |
6 |
No Pharmacokinetic Interaction Between Lacosamide and Carbamazepine in Healthy Volunteers
|
Cawello, Willi |
|
2010 |
50 |
4 |
p. 459-471 |
artikel |
7 |
Pharmacogenetic-Based Clinical Scores: A Useful, Simple Tool to Predict Tamoxifen-Based CYP2D6 Phenotype?
|
Fuhr, Uwe |
|
2010 |
50 |
4 |
p. 370-372 |
artikel |
8 |
Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual-Acting Angiotensin Receptor−Neprilysin Inhibitor (ARNi)
|
Gu, Jessie |
|
2010 |
50 |
4 |
p. 401-414 |
artikel |
9 |
Pharmacokinetics and Safety of Sunitinib Malate in Subjects With Impaired Renal Function
|
Khosravan, Reza |
|
2010 |
50 |
4 |
p. 472-481 |
artikel |
10 |
PhRMA Survey on the Conduct of First-in-Human Clinical Trials Under Exploratory Investigational New Drug Applications
|
Karara, Adel H. |
|
2010 |
50 |
4 |
p. 380-391 |
artikel |
11 |
Relationship Between Plasma Protease Inhibitor Concentrations and Lipid Elevations in HIV Patients on a Double-Boosted Protease Inhibitor Regimen (Saquinavir/Lopinavir/Ritonavir)
|
Rhee, Martin S. |
|
2010 |
50 |
4 |
p. 392-400 |
artikel |
12 |
Review: Clopidogrel Before Elective Percutaneous Coronary Intervention
|
Motovska, Zuzana |
|
2010 |
50 |
4 |
p. 373-379 |
artikel |
13 |
Silymarin Ascending Multiple Oral Dosing Phase I Study in Noncirrhotic Patients With Chronic Hepatitis C
|
Hawke, Roy L. |
|
2010 |
50 |
4 |
p. 434-449 |
artikel |